(1-(2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-yl)-4-methyl-1H-pyrrol-3-yl)methanol | 1307801-65-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (1-(2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-yl)-4-methyl-1H-pyrrol-3-yl)methanol
• 英文别名: [1-[2-[3,5-Dimethyl-4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]-4-methylpyrrol-3-yl]methanol
• CAS: 1307801-65-5
• 化学式: C₂₄H₃₁N₅O₂
• 分子量: 421.542
• InChiKey: SRNXEDDTIMPMGE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  31
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  75.4
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (1-(2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-yl)-4-methyl-1H-pyrrol-3-yl)methanol 在 重铬酸吡啶 、 三乙酰氧基硼氢化钠 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 1-((1-(2-((3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)-4-methyl-1H-pyrrol-3-yl)methyl)azetidin-3-ol
  参考文献：
  名称：

  Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors

  摘要：

  A series of pyrazolylpyrimidine scaffold based Syk inhibitors were synthesized and evaluated for their biological activities and selectivity. Lead optimization efforts provided compounds with potent Syk inhibition in both enzymatic and TNF-a release assay. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.09.011
• 作为产物：
  描述：

  4-甲基吡咯-3-甲酸乙酯 在 盐酸 、 lithium aluminium tetrahydride 、 potassium carbonate 、 间氯过氧苯甲酸 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 水 、 乙腈 为溶剂， 生成 (1-(2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-yl)-4-methyl-1H-pyrrol-3-yl)methanol
  参考文献：
  名称：

  Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors

  摘要：

  A series of pyrazolylpyrimidine scaffold based Syk inhibitors were synthesized and evaluated for their biological activities and selectivity. Lead optimization efforts provided compounds with potent Syk inhibition in both enzymatic and TNF-a release assay. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.09.011

文献信息

• Kinase Inhibitors
  申请人：Lee Jaekyoo

  公开号：US20110281841A1

  公开（公告）日：2011-11-17

  The present invention provides a new group of protein kinase inhibitors, pyrropyrimidine and pyrazolopyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof that are useful for treating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrropyrimidine and pyrazolopyrimidine derivatives.

  本发明提供了一种新的蛋白激酶抑制剂群，包括吡咯嘧啶和吡唑嘧啶衍生物，以及其药学上可接受的盐和前药，用于治疗细胞增殖性疾病和疾病，例如癌症、自身免疫性疾病、感染、心血管疾病和神经退行性疾病。本发明提供了合成和给药蛋白激酶抑制剂化合物的方法。本发明还提供了包含至少一种蛋白激酶抑制剂化合物和药学上可接受的载体、稀释剂或赋形剂的制剂。本发明还提供了在合成吡咯嘧啶和吡唑嘧啶衍生物的过程中产生的有用中间体。
• KINASE INHIBITORS
  申请人：Genosco

  公开号：EP2498607B1

  公开（公告）日：2016-02-17
• US8629132B2
  申请人：——

  公开号：US8629132B2

  公开（公告）日：2014-01-14
• Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors
  作者：Jang-Sik Choi、Hae-jun Hwang、Se-Won Kim、Byung Il Lee、Jaekyoo Lee、Ho-Juhn Song、Jong Sung Koh、Jung-Ho Kim、Phil Ho Lee

  DOI：10.1016/j.bmcl.2015.09.011

  日期：2015.10

  A series of pyrazolylpyrimidine scaffold based Syk inhibitors were synthesized and evaluated for their biological activities and selectivity. Lead optimization efforts provided compounds with potent Syk inhibition in both enzymatic and TNF-a release assay. (C) 2015 Elsevier Ltd. All rights reserved.